From Yahoo Finance: 2025-05-27 12:59:00

Barclays analyst Andrew Mok CFA maintains Equal Weight rating on Surgery Partners, Inc. (NASDAQ: SGRY) and reduces price target to $24 from $25. Company reported mixed fiscal Q1 2025 results, with effective physician recruitment but slower pricing growth. Around 150 new physicians added, revenue up 8.2% in the quarter, but missed earnings expectations. Surgery Partners, Inc. (NASDAQ: SGRY) saw net loss of $37.7 million in the quarter.

Surgery Partners, Inc. (NASDAQ: SGRY) provides surgical and related ancillary care solutions through its Surgical Facility Services, Ancillary Services, and Optical Services business segments. Despite potential, analyst sees greater promise in other AI stocks with 100x upside potential. Check out the report for the cheapest AI stock with significant gains.

Read more: Barclays Maintains Equal Weight Rating on Surgery Partners (SGRY), Cuts PT